Atlas Trials

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Clinical trial NCT01465997 · COMPLETED

Trial details

NCT number
NCT01465997
Sponsor
UCB BIOSCIENCES GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
EpilepsyMonotherapy
Start date
2012-05-01
Primary completion
2017-01-01
Enrollment
551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.